Intervention Review

Anti-tuberculous therapy for maintenance of remission in Crohn's disease

  1. Mark Borgaonkar2,
  2. Don MacIntosh3,
  3. John Fardy1,*,
  4. Lorinda Simms4

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 26 APR 1999

Assessed as up-to-date: 22 FEB 1999

DOI: 10.1002/14651858.CD000299


How to Cite

Borgaonkar M, MacIntosh D, Fardy J, Simms L. Anti-tuberculous therapy for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 1999, Issue 2. Art. No.: CD000299. DOI: 10.1002/14651858.CD000299.

Author Information

  1. 1

    Memorial University of Newfoundland, Dept. of Medicine Health Sciences Centre StJohn`s, CA-Newfoundland, Canada

  2. 2

    Memorial University of Newfoundland, Department of Medicine, St. John's, Newfoundland, Canada

  3. 3

    Dalhousie University, Halifax, Nova Scotia, Canada

  4. 4

    Eli Lilly and Company (Canada), Statistics and Information Sciences, Toronto, Ontario, Canada

*John Fardy, Dept. of Medicine Health Sciences Centre StJohn`s, Memorial University of Newfoundland, St John`s Centre, CA-Newfoundland, AIB 3V6, Canada. jfardy@mun.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 APR 1999

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. K. AKOBENG, Review article: the evidence base for interventions used to maintain remission in Crohn’s disease, Alimentary Pharmacology & Therapeutics, 2008, 27, 1
  2. 2
    Vivien E Rolfe, Paul J Fortun, Christopher J Hawkey, Fiona J Bath-Hextall, Probiotics for maintenance of remission in Crohn's disease, The Cochrane Library,